Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Clinical trial NCT06975410 · RECRUITING

Trial details

NCT number: NCT06975410
Sponsor: Yuhan Corporation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

EGFR Overexpression Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2025-06-12
Primary completion: 2027-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.